Liam O'Dowd - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Liam O'Dowd's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists todayLiam O'Dowd
Verified
Co-Founder and Editor, Leafie
Manchester
Beats
Biography
Editor of leafie, a pioneering media platform dedicated to exploring drugs and the cultural events that unite us. Founded in 2019, leafie has been at the forefront of providing unbiased and trustworthy information on substances like cannabis and psychedelics, fostering open dialogues and reshaping perceptions.
culture,Cannabis wellness and political issues., psychedelics entertainment, health
Business news
Content
By Liam O'Dowd| Leafie@ People in the UK who are prescribed medical cannabis through a private clinic can now request flower from the global cannabis brand Cookies, according to a press release seen by leafie. The first strain available, Hawaiian Rain, is a high-potency flower containing 31% THC. Priced at £11 a gram, it is the expensive flower available on prescription at the time of publication
By Liam O'Dowd| Leafie@ Patients prescribed medicinal cannabis in Australia showed improvements in their quality of life, fatigue and sleep disturbance over a 12-month period, according to new research published in the peer-reviewed journal PLOS One. The study, conducted by researchers from the University of Sydney, found that patients with anxiety, depression, insomnia and chronic pain also experienced sustained improvements in their condition-specific symptoms throughout the year-long assessment period
By Liam O'Dowd| Leafie@ A new study published in the Journal of Affective Disorders has shown that the mental health benefits of psilocybin, the main psychoactive compound found in magic mushrooms, may vary significantly depending on a person’s race. Researchers recruited almost 3,000 people in the US who planned to use psilocybin outside of a clinical setting to take part in a large-scale longitudinal survey
Company Info
Leafie
Leafie is an independent media platform established in 2019, dedicated to cannabis, psychedelics, and related cultural events. It provides unbiased information on these substances, highlighting their potential health and wellness benefits. As an online magazine, Leafie combines educational and entertaining content to engage both seasoned enthusiasts and newcomers. The platform offers content creation services, producing articles, interviews, and various media that explore the cultural, medical, and social aspects of cannabis and psychedelics. Additionally, Leafie features an online bookstore that includes first editions, signed copies, and rare publications related to these topics, catering to readers interested in in-depth literature. Leafie's content is aimed at a broad audience, including the general public and activists within the cannabis and psychedelics communities. Leafie operates as Leafie Limited, a private limited company registered in the UK, focusing on publishing activities.
Manchester, United Kingdom, United Kingdom
+44 20 8058 2166
Founded: 2019